KoBioLabs, Inc (KOSDAQ:348150)
South Korea · Delayed Price · Currency is KRW 5,330.00
+40.00 (0.76%)
At close: Apr 24, 2026
KoBioLabs Market Cap
KoBioLabs has a market cap or net worth of 103.5 billion as of April 24, 2026. Its market cap has increased by 27.50% in one year.
Market Cap
103.50B
Enterprise Value
87.13B
Revenue
69.29B
Ranking
n/a
PE Ratio
n/a
Stock Price
5,330.00
Market Cap Chart
Since November 18, 2020, KoBioLabs's market cap has decreased from 493.16B to 103.50B, a decrease of -79.01%. That is a compound annual growth rate of -24.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 103.50B | -6.98% |
| Dec 30, 2025 | 111.27B | 7.15% |
| Dec 30, 2024 | 103.84B | -35.34% |
| Dec 28, 2023 | 160.60B | -16.02% |
| Dec 29, 2022 | 191.23B | -42.95% |
| Dec 30, 2021 | 335.17B | -50.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NovMetaPharma | 124.56B |
| BIO-FD&C | 123.04B |
| Cell Biotech | 109.30B |
| TegoScience | 105.61B |
| Quratis | 99.23B |
| CTCBIO | 92.77B |
| CHA Vaccine Research Institute | 92.69B |
| Choong Ang Vaccine Laboratory | 92.03B |